Location · Texas
Clinical trials recruiting in Texas
1575 recruiting studies have at least one site in Texas; 474 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Texas.
1,575 recruiting studiesSource: ClinicalTrials.gov, refreshed October 27, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Dallas, TX + 20 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Location
- Houston, TX + 27 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
BOOM-IBD2 Pivotal Clinical Trial
Boomerang Medical
- Location
- Amarillo, TX + 15 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie
- Location
- Houston, TX + 14 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
HB-adMSCs for the Treatment of Crohn's Disease
Hope Biosciences Research Foundation
- Location
- Sugar Land, TX
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Bellaire, TX + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Dallas, TX + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Octapharma
- Location
- Houston, TX + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Renovion, Inc.
- Location
- Dallas, TX + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Regeneron Pharmaceuticals
- Location
- Austin, TX + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery
Intuitive Surgical
- Location
- Austin, TX + 5 other US sites
- Eligibility basics
- Ages 16–75
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- The Woodlands, TX + 11 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Austin, TX + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Houston, TX + 33 other US sites
- Eligibility basics
- Ages 45–75
- RecruitingPhase 3
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Zydus Therapeutics Inc.
- Location
- Houston, TX + 2 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ATLAS (AltaValve) Pivotal Trial
4C Medical Technologies, Inc.
- Location
- Houston, TX + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Walden Biosciences
- Location
- Houston, TX + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Austin, TX + 20 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Arlington, TX + 28 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
FORWARD CAD IDE Study
Shockwave Medical, Inc.
- Location
- Dallas, TX + 27 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Insulet Corporation
- Location
- Austin, TX + 25 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Insulet Corporation
- Location
- Houston, TX + 10 other US sites
- Eligibility basics
- Ages 14–75
- RecruitingPhase 1/Phase 2
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Aurinia Pharmaceuticals Inc.
- Location
- Houston, TX + 9 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- Bellaire, TX + 26 other US sites
- Eligibility basics
- Ages 18–75